Literature DB >> 31944109

Combined Computational and Structural Approach into Understanding the Role of Peptide Binding and Activation of Melanocortin Receptor 4.

Julian Zachmann1, Eftichia Kritsi2, Anthi Tapeinou3, Panagiotis Zoumpoulakis2, Theodore Tselios3, Minos-Timotheos Matsoukas4,1.   

Abstract

Melanocortin receptor 4 (MC4R) is expressed predominantly in the central nervous system and regulates food intake and sexual function and is also thought to be responsible for effects on mood and cognition. It belongs to the melanocortin receptor subfamily of G protein-coupled receptors (GPCRs). Here, we have synthesized and structurally characterized three peptides that bind to MC4R, producing different signaling events. AgRP is a naturally occurring antagonist, HLWNRS is the minimal sequence of the N-terminal with partial agonist activity, and aMSH is a full agonistic peptide. By implementing molecular dynamics simulations on the different peptide-receptor complexes, we propose their molecular basis of binding to investigate their differential molecular properties regarding the activation states of the receptor. Our analysis shows that the agonist and partial agonist may induce rotation in transmembrane helix 3, which is known to be involved in the key events occurring during GPCR activation, and this movement is impacted by certain aromatic residues and their positioning in the orthosteric binding site of the receptor.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31944109     DOI: 10.1021/acs.jcim.9b01196

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  1 in total

1.  Whole Exome Sequencing in Multi-Incident Families Identifies Novel Candidate Genes for Multiple Sclerosis.

Authors:  Julia Horjus; Tineke van Mourik-Banda; Marco A P Heerings; Marina Hakobjan; Ward De Witte; Dorothea J Heersema; Anne J Jansen; Eva M M Strijbis; Brigit A de Jong; Astrid E J Slettenaar; Esther M P E Zeinstra; Erwin L J Hoogervorst; Barbara Franke; Wiebe Kruijer; Peter J Jongen; Leo J Visser; Geert Poelmans
Journal:  Int J Mol Sci       Date:  2022-09-28       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.